1-5 of 5
Jeremy T. Baeten
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNA Hypomethylation Is Not Sufficient to Account for Decitabine Mediated Cytotoxicity in TP53 -Mutated Myeloid Malignancies

Jeremy T. Baeten, Sumedha Agashe, Annabel Quinet, Jamie Butler, Amber C. Carter, Jack Wooldridge, Kimberly Johansson, Geoffrey L. Uy, Alessandro Vindigni, Daniel C. Link
Journal: Blood
Blood (2024) 144 (Supplement 1): 5783.
https://doi.org/10.1182/blood-2024-211001
Published: 2024
Journal Articles

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Jeremy T. Baeten, Irenaeus C.C. Chan, Lea Moukarzel, Amber C. Carter, Minal Patel, Konrad H. Stopsack, Paul Pharoah, James Brenton, Bob T Li, Wassim Abida, Alison M. Schram, Karen Cadoo, Britta Weigelt, Carlos Cruchaga, Howard Scher, Ross L Levine, Elli Papaemmanuil, Daniel C. Link, Kelly L. Bolton
Journal: Blood
Blood (2023) 142 (Supplement 1): 1315.
https://doi.org/10.1182/blood-2023-190457
Published: 2023
Journal Articles

Targeting ATR in TP53 -Mutant AML/MDS

Jeremy T Baeten, Sumedha Agashe, Annabel Quinet, Kimberly B. Johansson, Alessandro Vindigni, Geoffrey L. Uy, Daniel C. Link
Journal: Blood
Blood (2022) 140 (Supplement 1): 8787–8788.
https://doi.org/10.1182/blood-2022-170238
Published: 2022
Journal Articles

TP53 Null AML Line Does Not Selectively Expand Under Lenalidomide Treatment

Kimberly B. Johansson, Jeremy T Baeten, Daniel C. Link
Journal: Blood
Blood (2021) 138 (Supplement 1): 4704.
https://doi.org/10.1182/blood-2021-148606
Published: 2021
Journal Articles

Effects of PARP Inhibitor Therapy on p53-Deficient Hematopoietic Stem and Progenitor Cell Fitness

Jeremy T Baeten, Irenaeus C.C. Chan, Daniel C. Link, Kelly L. Bolton
Journal: Blood
Blood (2021) 138 (Supplement 1): 3275.
https://doi.org/10.1182/blood-2021-151373
Published: 2021